COVID-19 SARS-CoV-2 Antibody Testing Study (SATS)

King's College London

Status: Unknown

Conditions: Healthy

Study type: Observational

Funder types: Other

Identifiers

NCT05009888

302225

Details and patient eligibility

About

SATS is a single site feasibility study to assess the practical and psychological feasibility of using rapid COVID antibody testing of blood obtained from fingertip pin-pricks.

Full description

SATS is a feasibility study conducted at a single site - King's College London and South London and Maudsley staff working at the Institute of Psychiatry, Psychology and Neuroscience (IoPPN) at Denmark Hill, London, England. The practical and psychological feasibility of using rapid COVID antibody testing of blood obtained from fingertip pin-pricks will be assessed.

Enrollment: 400 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• King's College Staff member
• Aged 18 years or over
• Able to freely give informed consent

Exclusion criteria

The participant may not enter the study if ANY of the following apply:

• known to have an infectious disease including a current SARS-CoV-2 infection.

• Any significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the research study, or may influence the result of the research study, or the participant's ability to participate in the research study. Examples of disorders or diseases which would be excluded include:

  • Medically diagnosed bleeding disorder;
  • Medically diagnosed platelet disorder;
  • Anticoagulant medication.

Trial design

400 participants in 1 patient group

Adult KCL IoPPN Staff

Description:

Freely consenting Adult KCL Staff attending King's College London, IoPPN, Denmark Hill site will all have an antibody test on finger prick blood. The antibody test will give a rapid result for the presence of IgG or IgM antibodies to COVID-19